Large-scale testing (Phase 3)Looking for participantsNCT07007065
What this trial is testing
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
Who this might be right for
Neovascular Age-related Macular Degeneration
AbbVie 561